Counterfeit clippings: news in brief
The Pharmaceutical Research and Manufacturers of America (PhRMA) has been denied involvement in an ongoing lawsuit in Maine, US, which is trying to repeal a law that allows state residents to buy medicines from other countries such as Canada, reports Pharmalot. The drug industry organisation has been using the lawsuit as a platform to warn of the dangers of allowing people to import drugs from overseas, which it maintains raises the risk of exposure to falsified, expired or low quality medicines. The judge in the case has concluded however that PhRMA should be shut out from proceedings because it was unable to demonstrate how drugmakers could be harmed by the law. Responding to its exclusion, PhRMA associate general counsel John Murphy said the organisation “continues to believe that Maine’s drug importation law conflicts with FDA’s authority to regulate prescription medication distribution in the US.”
Related Posts
2.7 kg gold seized from passenger at Hyderabad Airport
Hyderabad, April 29 (IANS) Customs officials at the Rajiv Gandhi International...
Tobacco smuggling Gibraltar border row
The difference in the price of tobacco is fuelling an illegal trade of smuggling...
Bulgarian jailed for smuggling 180,000 cigarettes
October 27, 2014 | Dover-express A VAN driver who smuggled almost 180,000...
Counterfeit Avastin shipped to Europe as well as US
Counterfeit versions of Roche's cancer drug Avastin, which caused a stir in the...